BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 272945)

  • 1. Vincristine, prednisone and L-asparaginase in the induction of remission in children with acute lymphoblastic leukemia following relapse.
    Kung FH; Nythan WL; Cuttner J; Falkson G; Lanzkowsky P; Del Duca V; Nawabi IU; Koch K; Pluess H; Freeman A; Burgert EO; Leone LA; Ruymann F; Patterson RB; Degnan T; Hakami N; Pajak TF; Holland J
    Cancer; 1978 Feb; 41(2):428-34. PubMed ID: 272945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-asparaginase used with cytosine arabinoside in treatment of childhood acute lymphocytic leukemia refractory to vincristine and prednisone.
    Smithson WA; Gilchrist GS; Burgert EO
    Med Pediatr Oncol; 1979; 6(2):163-70. PubMed ID: 287856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy with cyclophosphamide, vincristine, cytosine arabinoside, and prednisone (COAP) in childhood acute lymphoblastic leukemia (ALL).
    Sallan SE; Camitta BM; Chan DM; Traggis D; Jaffe N
    Med Pediatr Oncol; 1977; 3(4):359-64. PubMed ID: 270608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia.
    Ortega JA; Nesbit ME; Donaldson MH; Hittle RE; Weiner J; Karon M; Hammond D
    Cancer Res; 1977 Feb; 37(2):535-40. PubMed ID: 264412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refractory leukemia treated with cytosine arabinoside and cyclophosphamide.
    Ansari BM; Thompson EN
    Cancer; 1973 Aug; 32(2):294-7. PubMed ID: 4516215
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclophosphamide-asparaginase- vincristine-prednisone induction therapy in childhood acute lymphocytic and nonlymphocytic leukemia.
    Komp DM; George SL; Falletta J; Land VJ; Starling KA; Humphrey GB; Lowman J
    Cancer; 1976 Mar; 37(3):1243-7. PubMed ID: 1063049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy of acute lymphoblastic leukemia in children.
    Haghbin M
    Am J Hematol; 1976; 1(2):201-9. PubMed ID: 1069475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of cytosine arabinoside (NSC-63878) synchronization plus vincristine (NSC-67574), prednisone (NSC-10023), and L-asparaginase (NSC-109229) for remission induction in advanced acute leukemia in children.
    Sutow WW; Thomas D; Steuber CP; Pullen J; Vats T; Bryan JH; Morgan SK
    Cancer Treat Rep; 1976 May; 60(5):591-4. PubMed ID: 991148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Letter: Acute lymphoid leukemia: constant induction of remission by the combination of prednisone, vincristine and L-asparaginase (20 cases)].
    Mathe G; Pouillart P; De Vassal F; Delgado M; Schwarzenberg L; Misset JL; Hayat M; Jasmin C; Belpomme D; Musset M
    Nouv Presse Med; 1976 Jun; 5(23):1491. PubMed ID: 1064849
    [No Abstract]   [Full Text] [Related]  

  • 10. Combination chemotherapy in malignant diseases.
    Fairley GH
    J R Coll Physicians Lond; 1971 Jan; 5(2):167-77. PubMed ID: 4950464
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclophosphamide (NSC-26271) maintenance therapy after a second remission of childhood acute lymphoblastic leukemia: comparative clinical trial (standard dose versus intermittent high dose versus cyclophosphamide plus cytosine arabinoside (NSC-63878)).
    Albo V; Movassaghi N; Sitarz AL; Hammond D; Weiner J; Reed A
    Cancer Chemother Rep; 1975; 59(6):1097-102. PubMed ID: 769949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vincristine and prednisone vs vincristine, L-asparaginase, and prednisone for second remission induction of acute lymphocytic leukemia in children.
    Herson J; Starling KA; Dyment PG; Humphrey GB; Pullen J; Vats T
    Med Pediatr Oncol; 1979; 6(4):317-23. PubMed ID: 384187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of acute lymphoblastic leukemia].
    Paolucci G; Rosito P
    Minerva Pediatr; 1971 Nov; 23(44):1851-69. PubMed ID: 4950250
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined modality therapy of acute lymphocytic leukemia.
    Simone JV; Aur RJ; Hustu HO; Verzosa M; Pinkel D
    Cancer; 1975 Jan; 35(1):25-35. PubMed ID: 1053694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute lymphoblastic leukemia in adults and children. Differences in response with similar therapeutic regimens.
    Gee TS; Haghbin M; Dowling MD; Cunningham I; Middleman MP; Clarkson BD
    Cancer; 1976 Mar; 37(3):1256-64. PubMed ID: 1063050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy of childhood acute lymphoblastic leukemia.
    Bell BA; Whitehead VM
    Dev Pharmacol Ther; 1986; 9(3):145-70. PubMed ID: 3519131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urticaria pigmentosa and acute lymphoblastic leukemia.
    Fromer JL; Jaffe N
    Arch Dermatol; 1973 Feb; 107(2):283-4. PubMed ID: 4510082
    [No Abstract]   [Full Text] [Related]  

  • 18. Remission induction with L-asparaginase, vincristine, and prednisone in children with acute nonlymphoblastic leukemia.
    Land VJ; Sutow WW; Dyment PG; Falletta JM; Morgan SK; Bryan J
    Med Pediatr Oncol; 1976; 2(2):191-8. PubMed ID: 1066523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of adult acute lymphoblastic leukemia with cytosine arabinoside, vincristine, and prednisone.
    Gingrich RD; Armitage JO; Burns CP
    Cancer Treat Rep; 1978 Sep; 62(9):1389-91. PubMed ID: 356988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute leukemia in adults: assessment of remission induction with combination chemotherapy by clinical and cell-culture criteria.
    Curtis JE; Cowan DH; Bergsagel DE; Hasselback R; McCulloch EA
    Can Med Assoc J; 1975 Aug; 113(4):289-94. PubMed ID: 1056807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.